These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32184843)

  • 21. Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4
    Venugopala KN; Kandeel M; Pillay M; Deb PK; Abdallah HH; Mahomoodally MF; Chopra D
    Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32878018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
    He X; Alian A; Stroud R; Ortiz de Montellano PR
    J Med Chem; 2006 Oct; 49(21):6308-23. PubMed ID: 17034137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Basis for Inhibition of Enoyl-[Acyl Carrier Protein] Reductase (InhA) from Mycobacterium tuberculosis.
    de Ávila MB; Bitencourt-Ferreira G; de Azevedo WF
    Curr Med Chem; 2020; 27(5):745-759. PubMed ID: 30501592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
    Inturi B; Pujar GV; Purohit MN
    Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.
    Parikh SL; Xiao G; Tonge PJ
    Biochemistry; 2000 Jul; 39(26):7645-50. PubMed ID: 10869170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
    Holas O; Ondrejcek P; Dolezal M
    J Enzyme Inhib Med Chem; 2015; 30(4):629-48. PubMed ID: 25383419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives.
    Younis MH; Mohammed ER; Mohamed AR; Abdel-Aziz MM; Georgey HH; Abdel Gawad NM
    Bioorg Chem; 2022 Jul; 124():105807. PubMed ID: 35487073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking.
    Modi P; Patel S; Chhabria MT
    J Biomol Struct Dyn; 2019 Apr; 37(7):1736-1749. PubMed ID: 29663870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.
    Shilpi JA; Ali MT; Saha S; Hasan S; Gray AI; Seidel V
    In Silico Pharmacol; 2015 Dec; 3(1):10. PubMed ID: 26820895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
    Tripathi A; Wadia N; Bindal D; Jana T
    Indian J Biochem Biophys; 2012 Dec; 49(6):435-41. PubMed ID: 23350278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.
    Oliveira JS; de Sousa EH; de Souza ON; Moreira IS; Santos DS; Basso LA
    Curr Pharm Des; 2006; 12(19):2409-24. PubMed ID: 16842188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
    Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
    Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis.
    Chollet A; Stigliani JL; Pasca MR; Mori G; Lherbet C; Constant P; Quémard A; Bernadou J; Pratviel G; Bernardes-Génisson V
    Chem Biol Drug Des; 2016 Nov; 88(5):740-755. PubMed ID: 27301022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Synthesis of Quinazolinone-Triazole Hybrids as Potent Anti-Tubercular Agents.
    Dutta A; Trivedi P; Gehlot PS; Gogoi D; Hazarika R; Chetia P; Kumar A; Chaliha AK; Chaturvedi V; Sarma D
    ACS Appl Bio Mater; 2022 Sep; ():. PubMed ID: 36053225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid.
    Pflégr V; Maixnerová J; Stolaříková J; Pál A; Korduláková J; Trejtnar F; Vinšová J; Krátký M
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
    Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
    Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies.
    Venugopala KN; Chandrashekharappa S; Deb PK; Al-Shar'i NA; Pillay M; Tiwari P; Chopra D; Borah P; Tamhaev R; Mourey L; Lherbet C; Aldhubiab BE; Tratrat C; Attimarad M; Nair AB; Sreeharsha N; Mailavaram RP; Venugopala R; Mohanlall V; Morsy MA
    Int J Biol Macromol; 2024 Jun; 274(Pt 2):133285. PubMed ID: 38925196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
    Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.